New England Research & Management, Inc. Illumina, Inc. Transaction History

New England Research & Management, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 20, 2022	SELL	$181.58 - $368.0 $115,848 - $234,784	-638 Closed	0 $0
Q1 2022 Apr 20, 2022	SELL	$303.87 - $423.8 $8,508 - $11,866	-28 Reduced 4.2%	638 $223,000
Q4 2021 Jan 05, 2022	SELL	$347.28 - $421.83 $532,727 - $647,087	-1,534 Reduced 69.73%	666 $253,000
Q3 2021 Oct 08, 2021	BUY	$405.61 - $524.84 $892,342 - $1.15 Million	2,200 New	2,200 $892,000

876

139M

1.09M

1.91M

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $16.6B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

Get notified when there are updates to the investment portfolio of New England Research & Management, Inc., based on Form 13F filings with the SEC.

Stay updated on New England Research & Management, Inc. with notifications on news.